Morningstar

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference

The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.
Business Wire

PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
Morningstar

Publication in Vaccine Highlights Fewer Adverse Events with PharmaJet Needle-free Intradermal Delivery compared to Needle and Syringe

There were significantly fewer adverse events associated with needle-free Tropis ® intradermal (ID) delivery as compared to needle and syringe (N/S). Tropis ID delivery was preferred over N/S ID ...
GEN

Sparing Patients the Needle Remains a Priority

Three-quarters of biologic drugs cannot be delivered orally, and this has forced makers of most novel drugs to think about delivery. If a protein or peptide must be injected, makers then are seeking ...